...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Need An Explanation
6
May 17, 2016 11:09AM

San Fran,

Have you contacted Zenith regarding your excellent questions? If not you should. I just sent an email a few minutes ago with some similar questions. The more we badger them, the more likely we will be to receive an individual response or better yet get a corporate update or webcast.

They have no significant events left on their Q2 calendar. They are attending but not presenting at ASCO and Bio International Convention in June. Yes, Resverlogix is busy between now and mid-June, but Zenith has no excuses.

I too am puzzled by this private placement and not sure to be encouraged or discouraged. I can see both spins but without more info from Zenith it is impossible to know what is the reasoning.

BearDownAZ

5
May 17, 2016 11:34AM
5
May 17, 2016 11:35AM
3
May 17, 2016 11:38AM
5
May 17, 2016 02:06PM
3
May 17, 2016 03:21PM
1
May 17, 2016 04:08PM
4
May 17, 2016 04:28PM
2
May 17, 2016 05:10PM
3
May 17, 2016 06:26PM
1
May 17, 2016 10:10PM
3
May 18, 2016 07:05AM
Share
New Message
Please login to post a reply